Surfactant content in children with inflammatory lung disease
- PMID: 8681574
- DOI: 10.1097/00003246-199606000-00029
Surfactant content in children with inflammatory lung disease
Abstract
Objective: To determine surfactant profiles of tracheal secretions in mechanically ventilated children with respiratory failure secondary to bacterial pneumonia, viral pneumonitis, adult respiratory distress syndrome (ARDS), and cardiopulmonary bypass.
Design: Prospective, cohort study.
Setting: Tertiary, multidisciplinary, pediatric intensive care unit.
Patients: One hundred twenty pediatric patients with respiratory failure requiring mechanical ventilation.
Interventions: Routine tracheal aspirates were collected from children with bacterial pneumonia, viral pneumonitis, ARDS, postcardiopulmonary bypass, and a postsurgical control group. Samples were obtained on days 1, 2, 3, after every week of intubation and on the day of extubation.
Measurements and main results: The tracheal aspirates were analyzed by high-performance liquid chromatography for lecithin/sphingomyelin rations and by enzyme-linked immunosorbent assay for surfactant proteins A and B. Lung compliance and the oxygenation index were measured on each day of sample collection. On day 1, patients with bacterial pneumonia, viral pneumonitis, and ARDS had decreased lecithin/sphingomyelin ration (p < .001), and those patients with bacterial pneumonia and viral pneumonitis had decreased surfactant protein A/protein concentration (p < .001). The lecithin/sphingomyelin ratios and surfactant protein A/protein concentration were significantly different among the groups (p < .001), with the bacterial pneumonia and viral pneumonitis groups having higher lecithin/sphingomyelin ratios and increased surfactant protein concentrations before extubation. Pulmonary compliance was lower and the oxygenation index was higher than controls (p < .001) in patients with bacterial pneumonia, viral pneumonitis, and ARDS. Pulmonary compliance was correlated weakly with lecithin/sphingomyelin ratio (r2 = .11, p < .001) and surfactant protein A/protein concentration (r2 = .03, p < .05). Surfactant protein B was similar in the diagnostic groups. Surfactant content in tracheal secretions from cardiopulmonary bypass patients was equivalent to controls.
Conclusion: Abnormal tracheal aspirate surfactant phospholipids and surfactant protein A were noted in children with bacterial pneumonia, viral pneumonitis, and ARDS, but not in children on cardiopulmonary bypass.
Comment in
-
Surfactant is a target during acute lung injury inflammation.Crit Care Med. 1996 Jun;24(6):916-7. doi: 10.1097/00003246-199606000-00006. Crit Care Med. 1996. PMID: 8681590 No abstract available.
Similar articles
-
Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children.Crit Care Med. 2003 Jan;31(1):284-90. doi: 10.1097/00003246-200301000-00045. Crit Care Med. 2003. PMID: 12545030 Clinical Trial.
-
Serial lecithin/sphingomyelin ratios and surfactant/albumin ratios in tracheal aspirates from term infants with respiratory failure receiving extracorporeal membrane oxygenation.Clin Chem. 1995 Aug;41(8 Pt 1):1182-8. Clin Chem. 1995. PMID: 7628095 Clinical Trial.
-
Phospholipid and surfactant protein A concentrations in tracheal aspirates from infants requiring extracorporeal membrane oxygenation.J Pediatr. 1992 Aug;121(2):271-4. doi: 10.1016/s0022-3476(05)81202-8. J Pediatr. 1992. PMID: 1640296
-
Pediatric acute lung injury.Paediatr Respir Rev. 2007 Dec;8(4):348-62. doi: 10.1016/j.prrv.2007.03.001. Epub 2007 Jun 7. Paediatr Respir Rev. 2007. PMID: 18005903 Review.
-
[Acute respiratory distress syndrome and pneumonia].Masui. 2013 May;62(5):547-56. Masui. 2013. PMID: 23772528 Review. Japanese.
Cited by
-
Staphylococcus aureus Lung Infection Results in Down-Regulation of Surfactant Protein-A Mainly Caused by Pro-Inflammatory Macrophages.Microorganisms. 2020 Apr 16;8(4):577. doi: 10.3390/microorganisms8040577. Microorganisms. 2020. PMID: 32316261 Free PMC article.
-
Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.J Clin Invest. 1999 Apr;103(7):1015-21. doi: 10.1172/JCI5849. J Clin Invest. 1999. PMID: 10194474 Free PMC article.
-
Rational use of mucoactive medications to treat pediatric airway disease.Paediatr Respir Rev. 2020 Nov;36:8-14. doi: 10.1016/j.prrv.2020.06.007. Epub 2020 Jun 16. Paediatr Respir Rev. 2020. PMID: 32653467 Free PMC article. Review.
-
Surfactant treatment for acute respiratory distress syndrome.Arch Dis Child. 1999 Mar;80(3):248-52. doi: 10.1136/adc.80.3.248. Arch Dis Child. 1999. PMID: 10325705 Free PMC article.
-
Surfactant for bacterial pneumonia in late preterm and term infants.Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008155. doi: 10.1002/14651858.CD008155.pub2. Cochrane Database Syst Rev. 2012. PMID: 22336836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical